List of Excipients in Branded Drug DIETHYLPROPION HCL

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Physicians Total Care Inc	DIETHYLPROPION HCL	diethylpropion hydrochloride	54868-1462	LACTOSE
Physicians Total Care Inc	DIETHYLPROPION HCL	diethylpropion hydrochloride	54868-1462	MAGNESIUM STEARATE
Physicians Total Care Inc	DIETHYLPROPION HCL	diethylpropion hydrochloride	54868-1462	STARCH, CORN
Physicians Total Care Inc	DIETHYLPROPION HCL	diethylpropion hydrochloride	54868-1462	TALC

Generic Drugs Containing DIETHYLPROPION HCL

Company	Ingredient	NDC	Excipient
Blenheim Pharmacal Inc	diethylpropion hydrochloride	10544-598	CARBOMER 934
Blenheim Pharmacal Inc	diethylpropion hydrochloride	10544-598	MANNITOL
Blenheim Pharmacal Inc	diethylpropion hydrochloride	10544-598	POVIDONE
Blenheim Pharmacal Inc	diethylpropion hydrochloride	10544-598	TARTARIC ACID

What are the Most Frequently-Used Excipients in DIETHYLPROPION HCL?

# Of NDCs	Excipient

Excipient Strategy and Commercial Opportunities for Diethylpropion HCl

Last updated: February 26, 2026

Diethylpropion HCl is an appetite suppressant approved for short-term management of obesity. Its commercial success depends on optimized formulation and an effective excipient strategy to ensure stability, bioavailability, and patient compliance.

---

What are the key formulation challenges for Diethylpropion HCl?

Diethylpropion HCl is a small molecule that degrades in certain conditions, affecting shelf life and efficacy. Specific challenges include:

• Chemical stability: Susceptible to hydrolysis and oxidation.
• Bioavailability: Limited by solubility in aqueous media.
• Palatability: Bitterness and unpleasant taste require taste-masking.
• Manufacturing consistency: Requires uniform dosage forms.

Addressing these challenges mandates a strategic selection of excipients to enhance stability, solubility, and patient acceptability.

---

What excipient types improve Diethylpropion HCl formulations?

1. Stabilizers

• Antioxidants (e.g., ascorbic acid, sodium metabisulfite): Prevent oxidation.
• Buffering agents (e.g., phosphate buffers): Maintain pH around 3-4 to maximize stability.

2. Solubilizers

• Cyclodextrins: Enhance solubility by forming inclusion complexes.
• Polyethylene glycol (PEG): Improve dissolution, especially in solutions.

3. Taste-masking Agents

• Sweeteners (e.g., aspartame, sucralose): Improve taste.
• Flavoring agents (e.g., menthol, fruit flavors): Increase patient compliance.

4. Disintegrants and Fillers

• Sodium starch glycolate: Promote rapid tablet disintegration.
• Microcrystalline cellulose: Provide structural integrity.

5. Binders and Lubricants

• Lactose or povidone: Bindercod tablets.
• Magnesium stearate: Lubricates the manufacturing process.

---

How does excipient choice influence commercial opportunities?

Optimization of excipients can lead to:

• Extended shelf life: Reduces logistics costs and increases marketability.

• Enhanced bioavailability: Enables lower doses, reducing costs and side effects.

• Patient adherence: Improved taste and ease of swallowing increase compliance.

• Differentiation: Innovative formulations with unique excipient combinations or delivery systems (e.g., orally disintegrating tablets, controlled-release) can command premium pricing.

---

What are current regulatory considerations for excipients in Diethylpropion HCl?

• GRAS status: Selected excipients must meet Generally Recognized As Safe (GRAS) criteria by the FDA.
• Excipients transparency: Increased demand for detailed excipient sourcing and safety data.
• Novel excipients: Limited use due to strict regulatory requirements; most formulations rely on well-established excipients to streamline approval.

Formulators targeting markets outside the U.S. must consider regional regulations, such as EMA guidelines or local pharmacopoeias.

---

What are the key opportunities for commercialization?

Opportunity	Description	Potential Impact
Formulation innovation	Develop fast-dissolving or sustained-release forms using novel excipients	Higher patient adherence, expanded indication base
Combination products	Pair Diethylpropion with other weight management agents	Market expansion, increased market share
Market-specific formulations	Tailor formulations for emerging markets focusing on stability	Access to growing economies
Manufacturing efficiency	Use excipients that simplify processes and reduce costs	Margins improvement, scalability

Major pharmaceutical companies and generics developers will leverage excipient strategies to differentiate and optimize products.

---

Key Takeaways

• Stabilizers, solubilizers, taste-masking agents, and excipients for manufacturing are critical to formulation success.
• Optimized excipient selection can extend shelf life, improve bioavailability, and increase patient adherence.
• Regulatory adherence and transparency influence excipient choice.
• Commercial opportunities include formulation innovation, combination products, and market-specific customizations to meet evolving regulatory and patient needs.

---

FAQs

1. What excipients are most commonly used in Diethylpropion HCl tablets?
Buffering agents, such as phosphate buffers; fillers like microcrystalline cellulose; binders like povidone; and lubricants like magnesium stearate.

2. Can novel excipients improve Diethylpropion HCl bioavailability?
Yes, cyclodextrins or lipid-based excipients can enhance solubility and absorption.

3. How do excipients influence market differentiation for Diethylpropion HCl?
Innovative excipient combinations enable unique delivery forms, improve stability, or enhance taste, creating opportunities for premium products.

4. What regulatory hurdles exist for excipients in weight management drugs?
Excipients must meet safety standards set by regulatory agencies; novel excipients face strict approval processes.

5. Are controlled-release formulations feasible with current excipient technology?
Yes, using matrices or coating systems with specific polymers, controlled-release forms can be developed, extending dosing intervals.

---

References

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Excipients in Investigational New Drug Applications.
[2] McConville, J., & Kelly, D. (2017). Excipient innovations for drug delivery and formulation. International Journal of Pharmaceutics, 516(1-2), 549-558.
[3] Ghosh, P., et al. (2015). Advances in taste-masking techniques for oral drug delivery. Drug Development and Industrial Pharmacy, 41(10), 1693–1702.